Netherton Syndrome Market Increasing Number of Awareness Campaigns for Netherton Syndrome to Drive the Growth

Netherton Syndrome Market: Insight

According to The Insight Partners market research study of "Netherton Syndrome Market to 2027 – Global Analysis and Forecast by Therapy and Region," the global Netherton syndrome market is expected to reach US$ 74.31 million by 2027 from US$ 19.57 million in 2019; it is estimated to grow at a CAGR of 20.3% from 2020 to 2027. The report highlights trends prevailing in the global Netherton syndrome market, and the drivers and hindrances pertaining to the market growth.

Netherton syndrome is a rare disorder characterized by trichorrhexis invaginata, atopic diathesis, and ichthyosiform erythroderma. The trichorrhexis invaginata indicates short and brittle hair, atopic diathesis represents susceptibility to allergy problems while ichthyosiform erythroderma encompasses red, inflamed, scaly skin. Netherton syndrome is hereditary as it is an autosomal recessive trait. The disease is majorly caused due to mutations associated with SPINK5 gene. In some cases, although there is no family history of the disease, the syndrome is revealed even when two healthy parents that carry the mutated recessive gene have a child, which receives both copies of the recessive gene. The Netherton syndrome market is witnessing huge growth on the back of the increasing awareness regarding Netherton syndrome and growing number of product introductions. Moreover, rising number of clinical trials and robust pipeline of products act as significant opportunities for the future growth of the market players. However, the risk of adverse reactions associated with the Netherton syndrome treatment drugs restrains the growth of the market.

Download sample PDF Copy of Netherton Syndrome Market study at: https://www.theinsightpartners.com/sample/TIPRE00013771/

Netherton Syndrome Market Competitive Landscape

Lifemax Laboratories, Inc.; Azitra, Inc.; Sixera Pharma Ab; Dermelix Biotherapeutics; Matrisys Bioscience; Quoin Pharmaceuticals Ltd.; and Krystal Biotech, Inc. are a few of the leading companies operating in the Netherton syndrome market.

Increasing Number of Awareness Campaigns for Netherton Syndrome to Drive the Growth

Netherton syndrome is an autosomal recessive rare skin-related disorder that affects the hair, skin and immune system. The disease usually affects newborns in which, the skin is usually red and scaly as well as leak fluids in some cases. The patients suffering with this condition are usually unaware of the treatment options available as well as do not have easy access and ample information regarding the care to be taken. Awareness campaigns are impactful in terms of enabling timely and accurate diagnosis. Thus, various medical and social organizations are working towards spreading awareness and helping the patients suffering with Netherton syndrome around the world.

Foundation for Ichthyosis& Related Skin Types (FIRST) in collaboration with National Health Council (NHC) developed an organization that aims to improve lives and seek cures for the patients affected by ichthyosis and related skin types. The organization provides accurate and timely information regarding Netherton syndrome and ichthyosis that helps the patients to meet social, medical and educational needs of the disease community. Furthermore, the Ichthyosis Support Group (ISG) aims to protect and preserve the health and relieves patients affected by ichthyosis and other associated condition. The ISG provides information pack, distributes bulletins and newsletters organize children’s residential camps and others.

Netherton Syndrome Market: Segmentation

Based on therapy, the global Netherton syndrome market is segmented into keratolytic agents, oral and topical steroids and retinoids, topical calcineurin inhibitors, biological therapies, and radiation therapies. In 2019, the keratolytic agents segment held the largest share of the market. Growth of this segmental market is attributed to the increasing product launches and robust existing product pipeline. In addition, strategic activities by service providers such as collaborations, mergers and acquisitions, and expansions to expedite drug timeline are further accelerating the growth of the market. However, the biological therapy segment is projected to register the highest CAGR in the global Netherton syndrome market during 2020–2027.

Buy Complete Report of Netherton Syndrome Market Study at: https://www.theinsightpartners.com/buy/TIPRE00013771/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

E-mail: sam@theinsightpartners.com

Back to news